Related Experiment Video
Updated: May 25, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
[Vigilance for veterinary medicinal products: declarations of adverse reactions in the year 2010]
C R Müntener1, L Bruckner, A Stürer
1Institut für Veterinärpharmakologie und -toxikologie der Universität Zürich und Swissmedic, Schweizerisches Heilmittelinstitut, Bern. cedric.muentener@vetpharm.uzh.ch
Abstract:
In 2010, we observed again an increase in the number of declarations reported to the vigilance system for veterinary medicinal products up to a total of 160. The species and drug classes reported remained the same as in previous years: the majority of adverse drug reactions (ADRs) concerned either dogs or cats and the most frequently involved drugs were either antiparasitic products or antiinfectives. Adverse reactions following reconversions and 8 cases of suspected allergic reactions following the use of amoxicillin-clavulanic acid combinations in dogs were reported. Additional enquiries were processed by the Swiss Toxicological Information Centre and transmitted to Swiss medic. 11 of these reported accidental ingestions of flavoured tablets in overdose by dogs and some cats. The vaccino vigilance program received 179 declarations following immunization against blue tongue disease as well as 82 declarations following the application of other vaccines. The vigilance system increases the chance to identify rare reactions or interactions and thereby contributes to the security of veterinary medicinal products.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Allergic Reactions
FDA Approved Drugs: Changes to Approved Drugs
Therapeutic Drug Monitoring: Affecting Factors
Clinically Relevant Drug Product Specifications: Methods of Establishment

